UBS BiotechTop50 27Jun28

UBS BiotechTop50 27Jun28

BIOTEC.JO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$39.22M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
UBS BiotechTop50 27Jun28UBS BiotechTop50 27Jun280----

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$39.22 Million
Enterprise Value-
Earnings per Share$-
Beta0
Outstanding Shares-

Return

Return on EquityNaN%ROE
Return on AssetsNaN%
Return on Invested CapitalNaN%

Valuation & Multiples

P/E Ratio-P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About UBS BiotechTop50 27Jun28

Thematic tracking ETN issued by UBS AG, London Branch, that tracks the Bloomberg Transatlantic Top50 Biotech Net Return Index EUR, giving exposure to large US and European biotechnology companies. It is listed on the JSE, denominated in South African rand and expires on 27 June 2028.

Questions & Answers